This study aimed to assess plasma, urine, and tissue concentrations of laminin-5, collagen IV, and fibronectin in a control group and a group of renal cell carcinoma patients, the latter being divided into non-muscle-invasive and muscle-invasive subgroups. The gene discussed is FN1; the disease is hereditary clear cell renal cell carcinoma.